Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 138 Lymphoma, Non-Hodgkin 84 Lymphoma, Large B-Cell, Diffuse 83 Small Cell Lung Carcinoma 78 Hodgkin Disease 61 Precursor Cell Lymphoblastic Leukemia-Lymphoma 59 Leukemia 57 Burkitt Lymphoma 56 Lung Neoplasms 49 Lymphoma, Follicular 47 Lymphoma, Mantle-Cell 44 Leukemia, Myeloid, Acute 41 Lymphoma, Large-Cell, Immunoblastic 40 Multiple Myeloma 33 Leukemia, Lymphocytic, Chronic, B-Cell 33 Carcinoma, Non-Small-Cell Lung 30 Recurrence 26 Neuroblastoma 25 Lymphoma, B-Cell, Marginal Zone 25 Central Nervous System Neoplasms 24 Ovarian Neoplasms 18 Sarcoma 17 Brain Neoplasms 17 Dendritic Cell Sarcoma, Interdigitating 16 Congenital Abnormalities 16 Lymphoma, Large-Cell, Anaplastic 15 Breast Neoplasms 15 Testicular Neoplasms 14 Neoplasms, Plasma Cell 14 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13

Interventions

Sunitinib 5 pembrolizumab 4 Paclitaxel 4 Carboplatin 4 Radiotherapy 3 Cyclophosphamide 3 Cisplatin 3 selinexor 2 lenvatinib 2 Taxes 2 Ramucirumab 2 Octreotide 2 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Methylprednisolone 2 Erlotinib Hydrochloride 2 Chemoradiotherapy 2 zimberelimab 1 saracatinib 1 regorafenib 1 epacadostat 1 envafolimab 1 belinostat 1 avelumab 1 atezolizumab 1 amrubicin 1 alovudine 1 TP protocol 1 Radiofrequency Ablation 1 Radiation Dose Hypofractionation 1 Prednisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thymoma × Etoposide × Clear all

NCT00387868 2014-12-09

Preoperative Treatment of Patients With High Risk Thymoma

Valley Health System

Phase 2 Completed

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡